RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)
NCT06926244
·
clinicaltrials.gov ↗
RECRUITING
Status
800
Enrollment
OTHER
Sponsor class
Conditions
IgA Nephropathy (IgAN)
Sponsor
Assistance Publique - Hôpitaux de Paris